These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12067091)

  • 1. Misuse of randomization: a review of Chinese randomized trials of herbal medicines for chronic hepatitis B.
    Liu J; Kjaergard LL; Gluud C
    Am J Chin Med; 2002; 30(1):173-6. PubMed ID: 12067091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese medicinal herbs for chronic hepatitis B.
    Liu JP; McIntosh H; Lin H
    Cochrane Database Syst Rev; 2001; 2000(1):CD001940. PubMed ID: 11279742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews.
    He J; Du L; Liu G; Fu J; He X; Yu J; Shang L
    Trials; 2011 May; 12():122. PubMed ID: 21569452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese medicinal herbs for chronic hepatitis B: a systematic review.
    Liu J; McIntosh H; Lin H
    Liver; 2001 Aug; 21(4):280-6. PubMed ID: 11454192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.
    Zhang L; Wang G; Hou W; Li P; Dulin A; Bonkovsky HL
    Hepatology; 2010 Feb; 51(2):690-8. PubMed ID: 20101751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of RCTs and quasi-RCTs on traditional Chinese patent medicines for treatment of chronic hepatitis B.
    Zhan T; Wei X; Chen ZQ; Wang DS; Dai XP
    J Tradit Chin Med; 2011 Dec; 31(4):288-96. PubMed ID: 22462233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Xiaochaihu Tang for treatment of chronic hepatitis B: a systematic review of randomized trials].
    Qin XK; Li P; Han M; Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):312-20. PubMed ID: 20388470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systematic evaluation of random controlled trial on treatment of chronic hepatitis B by Chinese herbal medicine].
    Liu SP; Qin XK; McIntosh H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jan; 22(1):58-62, 64. PubMed ID: 12585176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Qualitative evaluation on literatures related with treatment of lung cancer with combined use of chemotherapy and Chinese herbs].
    Liu YL; Xu K; Bai JP; Li LN; Yang XB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Feb; 25(2):123-5. PubMed ID: 15768874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Error Matrix Tool to Overview the Validity of Evidence on Radix
    Liang N; Kong DZ; Ma SS; Lu CL; Yang M; Feng LD; Liu XH; Gluud C; Liu JP
    J Altern Complement Med; 2019 Sep; 25(9):957-973. PubMed ID: 30883184
    [No Abstract]   [Full Text] [Related]  

  • 11. Hot topics in Chinese herbal drugs research documented in PubMed/MEDLINE by authors inside China and outside of China in the past 10 years: based on co-word cluster analysis.
    Li HY; Cui L; Cui M
    J Altern Complement Med; 2009 Jul; 15(7):779-85. PubMed ID: 19534611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation on HBeAg conversion time when treating chronic hepatitis B patients with combination of lamivudine and traditional Chinese medicine].
    Bai SL; Hu XY; Zhong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1243-7. PubMed ID: 19173973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese herbal medicine and clomiphene citrate for anovulation: a meta-analysis of randomized controlled trials.
    See CJ; McCulloch M; Smikle C; Gao J
    J Altern Complement Med; 2011 May; 17(5):397-405. PubMed ID: 21563919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary analysis on the method of efficacy evaluation used in clinical articles issued in Chinese journal of integrated traditional and Western medicine].
    Li N; Xie ZF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jan; 24(1):72-4. PubMed ID: 14976898
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review.
    Chen Y; Zhu J
    J Viral Hepat; 2013 Jul; 20(7):445-52. PubMed ID: 23730837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
    McCulloch M; See C; Shu XJ; Broffman M; Kramer A; Fan WY; Gao J; Lieb W; Shieh K; Colford JM
    J Clin Oncol; 2006 Jan; 24(3):419-30. PubMed ID: 16421421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
    Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
    Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled trials of Chinese herbal medicine and conventional medicine comparative study.
    Shang A; Huwiler K; Nartey L; Jüni P; Egger M
    Int J Epidemiol; 2007 Oct; 36(5):1086-92. PubMed ID: 17602184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B].
    Wang SL; Yao NL; Lv WL
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2468-70. PubMed ID: 18330233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor reporting quality of key Randomization and Allocation Concealment details is still prevalent among published RCTs in 2011: a review.
    Clark L; Schmidt U; Tharmanathan P; Adamson J; Hewitt C; Torgerson D
    J Eval Clin Pract; 2013 Aug; 19(4):703-7. PubMed ID: 23648066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.